A Study to Evaluate Lymphoma Epidemiology

Overview

About this study

The purpose of this study is to build a large and diverse observational cohort to support broad and cutting-edge research focused on non-Hodgkin lymphoma (NHL) prognosis and survivorship.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients must be newly diagnosed within 6 months (180 days) of enrollment.
Patients may have been treated as long as initial non-Hodgkins Lymphoma (NHL) or Hodgkin's Lymphoma (HL) diagnosis is within 6 months of enrollment.
Patients must be 18 years or older.
Patients will be recruited regardless of human immunodeficiency virus (HIV) status.

Exclusion Criteria:

Patients less than 18 years of age.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
La Crosse, Wis. Mayo Clinic principal investigator Scott Okuno, M.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Tanner Reicks (507) 266-2656 Reicks.Tanner@mayo.edu
Mankato, Minn. Mayo Clinic principal investigator James Cerhan, M.D., Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Tanner Reicks (507) 266-2656 Reicks.Tanner@mayo.edu
Rochester, Minn. Mayo Clinic principal investigator James Cerhan, M.D., Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Tanner Reicks (507) 266-2656 Reicks.Tanner@mayo.edu
Eau Claire, Wis. Mayo Clinic principal investigator James Cerhan, M.D., Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Tanner Reicks (507) 266-2656 Reicks.Tanner@mayo.edu
Jacksonville, Fla. Mayo Clinic principal investigator Muhamad Alhaj Moustafa, M.D., M.S.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Tanner Reicks (507) 266-2656 Reicks.Tanner@mayo.edu
Albert Lea, Minn. Mayo Clinic principal investigator James Cerhan, M.D., Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Tanner Reicks (507) 266-2656 Reicks.Tanner@mayo.edu
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator James Cerhan, M.D., Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Tanner Reicks (507) 266-2656 Reicks.Tanner@mayo.edu
Austin, Minn. Mayo Clinic principal investigator James Cerhan, M.D., Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Tanner Reicks (507) 266-2656 Reicks.Tanner@mayo.edu

Mayo Clinic Location

Status

Contact